- Home
- Publications
- Publication Search
- Publication Details
Title
Graft versus Leukemia in 2023
Authors
Keywords
-
Journal
BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY
Volume -, Issue -, Pages 101476
Publisher
Elsevier BV
Online
2023-06-11
DOI
10.1016/j.beha.2023.101476
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Three FDA-approved therapies for chronic GVHD
- (2022) Robert Zeiser et al. BLOOD
- Triple post transplant cyclophosphamide (PTCY) based GVHD prophylaxis: HLA matched versus HLA haploidentical transplants
- (2022) Eugenio Galli et al. BONE MARROW TRANSPLANTATION
- The association of graft-versus-leukemia effect and graft-versus host disease in haploidentical transplantation with post-transplant cyclophosphamide for AML
- (2022) Avichai Shimoni et al. BONE MARROW TRANSPLANTATION
- Post-transplant cyclophosphamide alters immune signatures and leads to impaired T cell reconstitution in allogeneic hematopoietic stem cell transplant
- (2022) Chenchen Zhao et al. Journal of Hematology & Oncology
- Diagnosis and Management of AML in Adults: 2022 ELN Recommendations from an International Expert Panel
- (2022) Hartmut Döhner et al. BLOOD
- Advantages of peripheral blood stem cells from unrelated donors versus bone marrow transplants in outcomes of adult acute myeloid leukemia patients
- (2022) Tomoyasu Jo et al. CYTOTHERAPY
- MRD Tailored Therapy in AML: What We Have Learned So Far
- (2021) Lok Lam Ngai et al. Frontiers in Oncology
- The immunopeptidome guides permissive HLA mismatch
- (2021) Juliane Sarah Walz BLOOD
- Haploidentical age-adapted myeloablative transplant and regulatory and effector T cells for acute myeloid leukemia
- (2021) Antonio Pierini et al. Blood Advances
- “Ex‐vivo” T‐cell depletion in allogeneic hematopoietic stem cell transplantation for hematological malignancies: New clinical approaches for old challenges
- (2021) Miguel A. Diaz et al. EUROPEAN JOURNAL OF HAEMATOLOGY
- Non-classical manifestations of acute GVHD
- (2021) Robert Zeiser et al. BLOOD
- Regulatory T Cells in GVHD Therapy
- (2021) Wen-wen Guo et al. Frontiers in Immunology
- Novel Insights Into the Mechanism of GVHD-Induced Tissue Damage
- (2021) Takahide Ara et al. Frontiers in Immunology
- Relevance of Polymorphic KIR and HLA Class I Genes in NK-Cell-Based Immunotherapies for Adult Leukemic Patients
- (2021) Léa Dubreuil et al. Cancers
- Posttransplant cyclophosphamide as GVHD prophylaxis for peripheral blood stem cell HLA-mismatched unrelated donor transplant
- (2021) Monzr M. Al Malki et al. Blood Advances
- Signatures of GVHD and relapse after posttransplant cyclophosphamide revealed by immune profiling and machine learning
- (2021) Shannon R. McCurdy et al. BLOOD
- 2021 Update on MRD in acute myeloid leukemia: a consensus document from the European LeukemiaNet MRD Working Party
- (2021) Michael Heuser et al. BLOOD
- Umbilical Cord Blood Transplantation: Still Growing and Improving
- (2021) Xiaoyu Zhu et al. Stem Cells Translational Medicine
- Updates in chronic graft-versus-host disease
- (2021) Betty K. Hamilton Hematology-American Society of Hematology Education Program
- Extracorporeal Photopheresis (ECP) and the Potential of Novel Biomarkers in Optimizing Management of Acute and Chronic Graft vs. Host Disease (GvHD)
- (2020) Matthew Mankarious et al. Frontiers in Immunology
- Natural killer cells in cancer biology and therapy
- (2020) Song-Yang Wu et al. Molecular Cancer
- Minor Histocompatibility Antigen-Specific T Cells
- (2020) Corinne Summers et al. Frontiers in Pediatrics
- Adult cord blood transplant results in comparable overall survival and improved GRFS vs matched related transplant
- (2020) Prashant Sharma et al. Blood Advances
- Lower GVHD and relapse risk in PTCy-based Haploidentical vs Matched Sibling Donor RIC Transplant for Hodgkin Lymphoma
- (2019) Sairah Ahmed et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Posttransplantation cyclophosphamide prevents graft-versus-host disease by inducing alloreactive T cell dysfunction and suppression
- (2019) Lucas P. Wachsmuth et al. JOURNAL OF CLINICAL INVESTIGATION
- MRD in AML: The Role of New Techniques
- (2019) Maria Teresa Voso et al. Frontiers in Oncology
- Impact of Conditioning Intensity of Allogeneic Transplantation for Acute Myeloid Leukemia With Genomic Evidence of Residual Disease
- (2019) Christopher S. Hourigan et al. JOURNAL OF CLINICAL ONCOLOGY
- Immunological and Clinical Impact of Manipulated and Unmanipulated DLI after Allogeneic Stem Cell Transplantation of AML Patients
- (2019) Jochen Greiner et al. Journal of Clinical Medicine
- Long-Term Results of Prophylactic Donor Lymphocyte Infusions for Patients with Multiple Myeloma after Allogeneic Stem Cell Transplantation
- (2018) Maximilian Gröger et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Chronic graft-versus-host disease: current management paradigm and future perspectives
- (2018) Hani Mawardi et al. ORAL DISEASES
- Human γδ T-Cells: From Surface Receptors to the Therapy of High-Risk Leukemias
- (2018) Vito Pistoia et al. Frontiers in Immunology
- Development of Grade II Acute Graft-Versus-Host Disease is Associated with Improved Survival after Myeloablative HLA-Matched Bone Marrow Transplantation using Single-Agent Post-Transplant Cyclophosphamide
- (2018) Shannon R. McCurdy et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Mobilized Peripheral Blood Stem Cells Versus Unstimulated Bone Marrow As a Graft Source for T-Cell–Replete Haploidentical Donor Transplantation Using Post-Transplant Cyclophosphamide
- (2017) Asad Bashey et al. JOURNAL OF CLINICAL ONCOLOGY
- Myeloablative Versus Reduced-Intensity Hematopoietic Cell Transplantation for Acute Myeloid Leukemia and Myelodysplastic Syndromes
- (2017) Bart L. Scott et al. JOURNAL OF CLINICAL ONCOLOGY
- Prospective, Randomized, Double-Blind, Phase III Clinical Trial of Anti–T-Lymphocyte Globulin to Assess Impact on Chronic Graft-Versus-Host Disease–Free Survival in Patients Undergoing HLA-Matched Unrelated Myeloablative Hematopoietic Cell Transplantation
- (2017) Robert J. Soiffer et al. JOURNAL OF CLINICAL ONCOLOGY
- Acute Graft-versus-Host Disease — Biologic Process, Prevention, and Therapy
- (2017) Robert Zeiser et al. NEW ENGLAND JOURNAL OF MEDICINE
- Pathophysiology of Chronic Graft-versus-Host Disease and Therapeutic Targets
- (2017) Robert Zeiser et al. NEW ENGLAND JOURNAL OF MEDICINE
- Pathophysiology of GvHD and Other HSCT-Related Major Complications
- (2017) Sakhila Ghimire et al. Frontiers in Immunology
- How important is NK alloreactivity and KIR in allogeneic transplantation?
- (2016) Brian C. Shaffer et al. BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY
- Exploitation of natural killer cells for the treatment of acute leukemia
- (2016) Rupert Handgretinger et al. BLOOD
- Clinical separation of cGvHD and GvL and better GvHD-free/relapse-free survival (GRFS) after unrelated cord blood transplantation for AML
- (2016) C-C Zheng et al. BONE MARROW TRANSPLANTATION
- Donor Lymphocyte Infusions for Chronic Myeloid Leukemia Relapsing after Allogeneic Stem Cell Transplantation: May We Predict Graft-versus-Leukemia Without Graft-versus-Host Disease?
- (2015) Aleksandar Radujkovic et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Conditioning regimens for hematopoietic cell transplantation: one size does not fit all
- (2014) B. Gyurkocza et al. BLOOD
- HLA class II upregulation during viral infection leads to HLA-DP-directed graft-versus-host disease after CD4+ donor lymphocyte infusion
- (2013) S. Stevanovi et al. BLOOD
- "Designed" grafts for HLA-haploidentical stem cell transplantation
- (2013) M. F. Martelli et al. BLOOD
- Rituximab prophylaxis prevents corticosteroid-requiring chronic GVHD after allogeneic peripheral blood stem cell transplantation: results of a phase 2 trial
- (2013) C. Cutler et al. BLOOD
- Aldehyde Dehydrogenase Expression Drives Human Regulatory T Cell Resistance to Posttransplantation Cyclophosphamide
- (2013) C. G. Kanakry et al. Science Translational Medicine
- Prophylactic rituximab after allogeneic transplantation decreases B-cell alloimmunity with low chronic GVHD incidence
- (2012) S. Arai et al. BLOOD
- Deficiency of CD73/ecto-5'-nucleotidase in mice enhances acute graft-versus-host disease
- (2012) H. Tsukamoto et al. BLOOD
- Reduced-intensity conditioning versus standard conditioning before allogeneic haemopoietic cell transplantation in patients with acute myeloid leukaemia in first complete remission: a prospective, open-label randomised phase 3 trial
- (2012) Martin Bornhäuser et al. LANCET ONCOLOGY
- Successful transfer of alloreactive haploidentical KIR ligand-mismatched natural killer cells after infusion in elderly high risk acute myeloid leukemia patients
- (2011) A. Curti et al. BLOOD
- Impact of immune modulation with anti-T-cell antibodies on the outcome of reduced-intensity allogeneic hematopoietic stem cell transplantation for hematologic malignancies
- (2011) R. J. Soiffer et al. BLOOD
- Comparable survival after HLA-well-matched unrelated or matched sibling donor transplantation for acute myeloid leukemia in first remission with unfavorable cytogenetics at diagnosis
- (2010) V. Gupta et al. BLOOD
- Nonmyeloablative HLA-Haploidentical Bone Marrow Transplantation with High-Dose Posttransplantation Cyclophosphamide: Effect of HLA Disparity on Outcome
- (2009) Yvette L. Kasamon et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Outcome of patients developing GVHD after DLI given to treat CML relapse: a study by the chronic leukemia working party of the EBMT
- (2009) Y Chalandon et al. BONE MARROW TRANSPLANTATION
- Cord blood transplantation for haematological malignancies: conditioning regimens, double cord transplant and infectious complications
- (2009) Colleen Delaney et al. BRITISH JOURNAL OF HAEMATOLOGY
- Cord blood banking: ‘providing cord blood banking for a nation’
- (2009) Sergio Querol et al. BRITISH JOURNAL OF HAEMATOLOGY
- Instability of the transcription factor Foxp3 leads to the generation of pathogenic memory T cells in vivo
- (2009) Xuyu Zhou et al. NATURE IMMUNOLOGY
- HLA-Haploidentical Bone Marrow Transplantation for Hematologic Malignancies Using Nonmyeloablative Conditioning and High-Dose, Posttransplantation Cyclophosphamide
- (2008) Leo Luznik et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now